ARLINGTON HEIGHTS, Ill., April 6, 2011 /PRNewswire/ -- MEDX, Inc., a leading provider of nuclear medicine equipment, today introduced the next generation T-Quest™ compact gamma camera. The FDA-cleared T-Quest, includes enhanced thyroid imaging and now features expanded imaging capabilities to perform parathyroid, sentinel node, MUGA, gastric emptying, hepatobiliary, bone spots and other small organ studies. The Company also announced the first installations for the powerful new T-Quest at two leading acute care hospitals, Meritus Medical Center in Hagerstown, MD and St. Barnabas Medical Center in Livingston, NJ.
"We're pleased to see immediate market reaction to the expanded imaging capabilities of the powerful next generation T-Quest camera," said Sean McDermott, managing partner, MEDX, Inc. "Offering high quality imaging capabilities for thyroid and ancillary exams, the T-Quest enables sites to focus utilization of their dual-head cameras on high revenue exams that require a large field of view. This image quality and low lifetime system cost, offers medium to large hospitals and imaging centers a cost-effective tool to expand volume, improve efficiency and provide quality patient care."
Commercially available worldwide, the compact T-Quest provides high-quality imaging capabilities and the freedom to perform long duration time/activity studies. Its minimized focal distance and mm/pixel ratio maximizes diagnostic quality through improved image resolution. The results of this combination are increased operating efficiency, better imaging economics and improved diagnostic results. Requiring less than eight square feet of floor space, T-Quest is the smart choice for facilities operating with space and patient capacity limitations. The system features a 6 inch field of view and lightweight collimators which are easily changed by hand. Its unobtrusive design promotes patient comfort and is non-claustropho
|SOURCE MEDX, Inc.|
Copyright©2010 PR Newswire.
All rights reserved